Twist Bioscience Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T Cell Therapies

Twist Bioscience Corporation and MediSix Therapeutics announced a collaboration to discover novel antibodies against five undisclosed targets. Twist will leverage its proprietary Library of Libraries to discover five novel antibodies directed against MediSix’s targets.